Creation
Draft
Initial
Detailed
Accepted
Closed
Idea Description
Supplementary Information
Detailed Submission Data
Innovation 'Elevator Pitch':
Prompt is a back up memory app and web dashboard to help people with daily difficulty recalling essential information about people, places and events.
Overview of Innovation:
Prompt emulates the way memory works by collating personal context about people, places and events. It aims to manitain confidence and independence for people living with impaired memories, due to conditions such as early dementia, mild cognitive impairment or recovering from stroke, brain injury or chemotherapy. An app provides help in the hand by embedding images and contextual information in reminders as well as making it available through natural language search. A web dashboard is available for family, friends and carers to help manage content, send reminders and messages. Analytics track user behaviour and send alerts if change is detected. The system will also use personal data to surface useful information, such as reminders of regular events, even if they're not in the diary as well as offering support with current location and why a user might be at that place. Future panned developments include complete voice interaction and integration with sensors.

Prompt has been developed in consultation with clinicians, people living with dementia, recovering from stroke and brain injury and their families. Research has been supported by Alzheimer's Society, Headway and the Child Brain Injury Trust. Development has been supported by Nominet Trust, UnLtd and Innovate UK. The company has also recently completed the Health Social Innovators accelerator programme and recently won a european pitch competition run by disruptive transpsort company Uber,
Stage of Development:
Trial stage - Trial stage to prove that the idea actually works as intended
Similar Content3
Innovation 'Elevator Pitch':
Technology to assist older people living independently with declining cognition, who are at risk of hypothermia, dehydration, malnutrition and unattended falls.
Overview of Innovation:
Many older people want to live independently for as long as possible, causing anxiety for family and friends.  They are often in denial of their declining capacity, proud and won’t wear pendants. Especially with impaired cognition, many suffer from hypothermia, dehydration, malnutrition or unattended falls.  They are admitted to hospital needing longer treatment for poorer health outcomes and greater risk of transfer into a care home. 
 
To make sure that service users are warm, drinking, eating and moving around as normal, Kemuri checks every hour and provides actionable information and alerts for the families and carers.  It increases peace of mind in addition to better outcomes and reduced costs for services users, families and the public sector.
 
Kemuri looks like a Familiar Power Socket to the service user; no changes to life style, plug in kettle and microwave, not stigmatising, not intrusive and tamperproof.
 


Technically it is mains-powered, continuously monitoring five sensors and sending data via a mobile phone connection to the Internet.  It has internal battery back-up to report power loss. 
 
The Wellbeing Monitor App is designed for the families and carers of older vulnerable people who:
  • Want to live independently
  • Reject or forget pendant alarms
  • Deny declining capacity
  • Show symptoms of dementia
  • Remove things they don’t understand
  • Need daily monitoring
  
 
Predictive analytics check every hour for changes to patterns of motion and power usage.  If there are many changes, then alerts may be sent to families, carers or 24/7 response centres.
 
As stated by a Commissioning Manager at a County Council, “ ... this is a unique product ….  I think there’s potential here for both self funder and LA funding as a potential option that fills a gap that conventional telecare does not.”
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Clinical trials and evidence / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
The Kemuri Wellbeing Monitor is used the context of the care of older people living alone who are losing their ability to undertake Activities of Daily Living (ADL).  Research by the Institute of Ageing shows the range of pathways that people take before they are unable to live independently

Kemuri is effective when people are less mobile, possibly showing early symptoms of dementia.  They do not need, or welcome, daily contact and cannot, or will not, use pendant alarm systems.  They can be encouraged to continue living as actively as possible and maintain a reasonable quality of life for more years.  If people stay in the right hand side of the curve, average saving is £1900 per year.  People on the left hand side cost an extra £15,500 per year.

Kemuri’s hourly analysis of multiple sensor data enables people to gain insight into the risk of hypothermia, dehydration, malnutrition, unattended falls and power loss.  It is preventive telecare; unlike alarms that are reactive telecare.

The most common telecare service is the provision of pendant alarms.  Out of 1.6 million issued, 32% are never worn, only 8% are worn all the time, as prescribed.  These 500,000 unworn pendant alarms are ineffective for identifying falls, strokes or coma.  This wastes as much as £80 million per year.  Kemuri is passive telecare that continuously monitors ambient conditions and use of electrical devices e.g. kettles and microwaves.  

 
After an emergency admission into hospital, discharge to a residential care home is 2.5 times longer than discharge to independent living at home.
 

 
Including cost of stabilisation, treatment and excess bed days, this costs an average of £5000 more per non-elective hospital stay.  Preventive telecare with a wellbeing monitor and family intervention will help to minimise the number of patients suffering from hypothermia, dehydration, malnutrition and unattended falls.  People admitted in a healthier state are less complex to treat, have improved health outcomes and less likely to be readmitted.  
 
Kemuri is specifically designed for a cohort of older people who are often in denial of their declining ability.  Typically they won’t use their pendant alarms, reject wearable devices, have memory lapses and resist any changes to their normal routine.  Some may show other symptoms of the onset of dementia.  Many will be over 85 years old and not receiving regular visits from family or friends.
 
Initial Review Rating
2.80 (2 ratings)
Benefit to WM population:
West Midlands has a population of 5.6 million people covering an area of more than 5,000 square miles.  It is a region full of contrasts and diversity.  It includes the second largest urban area in the country (Birmingham, Solihull and the Black Country) yet over 80% of the area is rural.  It is the second most ethnically diverse region in the country after London.  There are probably 40,000 older people who might be suitable for passive wellbeing monitoring.  Many of these are admitted to hospital and may not be able to return to their own homes. 
 
Kemuri wellbeing monitoring can extend the period that older people can continue to live independently at home.  It avoids the stigma of wearables and unfamiliar sensors that can be damaged or removed.  A power socket is a very familiar device and installation does not require changes in patterns of normal behaviour.  They are easily installed into kitchens of sheltered accommodation.  Wardens or housing scheme managers can easily check wellbeing daily and avoid some of the tragic outcomes of unattended falls. 
 
Peace of mind is the greatest value for many families.  They can check daily, or even hourly, that people are living normally, fitting in with their own daily routines, from anywhere in the world.  They can be alerted if there are lots of changes that may give them concern.  Alerts can also be directed to 24/7 response centres.  They can confirm that domiciliary carers have provided drinks and meals at the time they were ordered.
 
Families spread over the world can be part of an older person’s care plan.  Social contact with the older person can be more directed and appear less intrusive.  You can ask if somebody had a nice day in the garden or slept well, in the full knowledge of activity in the kitchen at that time of day. 
 
Caring for older people is very time consuming and costly if professionals are used.  However, there are probably four times as many unpaid carers providing care on a voluntary basis.  There are also examples of people who have to give up their jobs in order to care for their vulnerable parents, this represents a loss to the local economy and taxable income.  Regular checks with the Kemuri well-being monitor could allow people to have more time for paid employment.  
Current and planned activity: 
After the completion of the Proof of Concept, Kemuri is now scaling up manufacture for B2B sales through accredited telecare service companies.  The first is Welbeing (Wealden and Eastbourne Lifeline), which has the telecare service contract for Staffordshire.  They have the capacity to install Kemuri anywhere in the Region.  Welbeing provides telecare for statutory bodies and self-funders.  The latter are increasing in number as many local authorities are reducing budgets for adult social care.
 
We are building batches of 100 units.  Many of the first batches can be made available for trials by health and social care clients.  Trials are necessary to collect evidence that preventive wellbeing monitoring does actually improve health outcomes and reduce time until discharge.   
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 
 
Note that the patent applies to more devices than a power socket.  It covers the internal electronics and components, which could be incorporated into any equipment consuming significant amounts of power. 
 
Kemuri and KemuriSense are registered trademarks.  
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
2
Regulatory Approvals:
The product has been prototyped and progressing through the Certification process. EMC compliance has been achieved and final Safety report for CE certification is expected in Feb 2016. 
 
It is not a medical device since it only measures ambient conditions.
Regional Scalability:
The production of smart power sockets is scalable from batches of 100 to 1000 per month in the production facilities in Woking.  Larger volumes could be obtained by second sourcing the manufacturer in the UK or overseas.
 
The Web technology is cloud-based and can be very rapidly scaled by commissioning more servers and storage at very short notice. 
 
The installation can be performed by our telecare service partner, Welbeing.  They are a growing company with over 60,000 service users in NHS Trusts, Social Services, sheltered housing and care agencies throughout the UK, including the West Midlands.   They offer a nationwide telecare service with 24/7/365 monitoring facilities in a TSA accredited contact centre.  
 
Kemuri is building up the operations support as it is recruiting more engineering and IT staff.
Measures:
In co-operation with an academic research partner, we expect to plan the following measures:
 
Quality
  • Continuous reliable operation
  • Avoidance of false alerts
  • Recognising unattended falls, strokes or other episodes that result in a carer taking action that saved time and cost for medical intervention.
  • Peace of mind achieved for families and carers
  • Identifying trends that indicate the risk of hypothermia, dehydration and malnutrition.
  • Identifying activity at unusual times of day that lead to helpful family or medical intervention
 
Safety
  • Electrical safety of products after installation in kitchens.
  • Security of personal data and avoidance of data loss.
 
Cost
  • The cost target is £2500 for each older person involved in the trial.  This would include the costs of selection, installation, monitoring, service support and questioning families throughout the trial.  Note that this includes detailed data analysis, medical services, the final report and communications.
  • The final operational cost target is £2 per day, to include installation, Web services, smartphone apps, technical support and reseller profit margin.   
 
People
The target group for research is a cohort that has these attributes:
  • Reject pendant alarms
  • Deny declining capacity
  • Want to live independently
  • Show symptoms of dementia
  • Need daily monitoring
A percentage will be used as a control group who are not included in the Trial. Finding these people may require the inspection of medical and social care records, which will need approval by an Ethics Committee.  
Adoption target:
Assuming that there are 500,000 unused pendants in the UK, there are approximately 30,000 candidates for Kemuri wellbeing monitoring in a West Midlands population of 5 million.   
 
The reasonable viable number is 300 (1% of WM total) – with an expectation to grow to 12,000 service users within 5 years (20% of WM total).  
Read more
Hide details
Innovation 'Elevator Pitch':
Protect people with dementia from unattended falls, dehydration, malnutrition and hypothermia by hourly checking patterns of normal activities in their kitchens. 
Overview of Innovation:
Many older people want to live independently for as long as possible, causing anxiety for family and friends.  They are often in denial of their declining capacity, proud and won’t wear pendants.  With impaired cognition, many suffer from unattended falls, dehydration, malnutrition or hypothermia.  They are admitted to hospital needing longer treatment for poorer health outcomes and greater risk of transfer into a care home. 

To make sure that service users are moving around as normal, drinking, eating and warm, Kemuri checks every hour.  It alerts families and carers of important changes and provides valuable details for guiding action.  Peace of mind results in better outcomes and reduced costs for everybody.

Kemuri does not stigmatise because it looks a familiar Power Socket to the service user.  There’s nothing to remember and people continue with normal activities such as boiling kettles and heating food in microwaves or other electrical equipment.


KemuriSense® mains Smart Power Sockets continuously monitor motion, power usage, temperature and humidity and send data via GSM mobile phone signals to the Internet.  Mains power loss is automatically reported whilst it continues to report other sensor readings.  

The Wellbeing Monitor App informs families and carers of older vulnerable people who:
  • Want to live independently
  • Reject or forget pendant alarms
  • Deny declining capacity
  • Show symptoms of dementia
  • Remove things they don’t understand
  • Need daily monitoring 


Predictive analytics check every hour for changes to patterns of motion and power usage.  If there are many changes, then alerts may be sent to families, carers or 24/7 response centres.

As stated by a Commissioning Manager at a County Council, “ ... this is a unique product ….  I think there’s potential here for both self funder and LA funding as a potential option that fills a gap that conventional telecare does not.”
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health
Benefit to NHS:
Dementia is increasing in the population. Kemuri is a tool for stabilising the wellbeing of older people living alone who are declining in their ability to undertake Activities of Daily Living. Better wellbeing means healthier people, better health outcomes & more efficient use of NHS resources. Institute of Ageing research shows a range of pathways that people take before they are unable to live independently.


Early intervention is proven to reduce costs significantly. Kemuri should be deployed as soon as people are showing early symptoms of dementia. With loss in mobility, falls are inevitable: half those 80+ fall at least once p.a. Falls cost the NHS £2bn p.a. People with dementia tend to forget their pendant alarms/wearable telecare devices. If unable to call for help they may suffer for days before discovery & admission to A&E with medical complications. Kemuri’s hourly analysis of patterns of motion power usage automatically alerts to the risk of unattended falls.

In comparison pendant alarms are ineffective with early stage dementia. Out of 1.6m issued 32% are never worn & only 8% are worn all the time as prescribed. 500,000 unworn pendant alarms waste as much as £80m p.a. Kemuri continuously monitors motion, learns patterns of activity without any cognitive input from the service user.


A value to the NHS of early A&E admission into hospital is better health outcomes & more people discharged back to independent living on average after 12.3 days (discharge to residential care on average 31.7 days, 2.5 times longer).



£5000 could be re-allocated for each episode avoiding discharge to a care home. Unattended falls longer than 24 hours result in stabilisation time, longer treatment & delayed transfers of care. Kemuri preventive telecare with a wellbeing monitor & daily attention will also help to minimise the number of patients suffering the effects of hypothermia, dehydration & malnutrition.
  • Cold homes cost the NHS in England more than £1.36bn p.a.
  • Dehydration complications include low blood pressure, weakness, dizziness, increased risk of falls, & pressure sores
  • Malnutrition costs the NHS £7bn p.a. Risk (in 2010) was 28% in patients < 60 years, 32% 60-79 years & 44% if > 80 years
Kemuri could be funded by the NHS for a few weeks after discharge on the grounds that people admitted in a healthier state are less complex to treat, have improved health outcomes & are less likely to be readmitted, with the ongoing service funded by Social Services or self-funders.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
West Midlands has a population of 5.6 million people covering an area of more than 5,000 square miles.  It is a region full of contrasts and diversity.  It includes the second largest urban area in the country (Birmingham, Solihull and the Black Country) yet over 80% of the area is rural.  It is the second most ethnically diverse region in the country after London.  There are probably 40,000 older people who might be suitable for passive wellbeing monitoring.  Many of these are admitted to hospital and may not be able to return to their own homes. 

Older people are at the focus of Kemuri wellbeing monitoring.  Hourly and daily pattern analysis reduces risk and extends the period that they can continue to live independently at home.  Everybody has access to information that reduces the risk of unattended falls, dehydration, malnutrition and hypothermia.  Alerts are automatic without older people having to change their life style.  A familiar power socket is not stigmatising or intrusive.  There are no wearable devices to remember or unfamiliar sensors to be discarded.  Discharge from hospital could be accelerated with a KemuriSense Power Socket pre-installed.

Families and carers use the Wellbeing App for peace of mind.  At any time of day, from anywhere in the World, people can view the changes to patterns of behaviour.  There’s an option to receive alerts after more changes than usual.  They can enquire about wellbeing with full knowledge of the predictive analysis and decide on appropriate action. Some of the tragic outcomes of unattended falls are avoidable with hourly monitoring.  Additionally, it’s possible to confirm that domiciliary carers have provided drinks and meals at the time they were ordered.

Service organisations benefit from accurate data.  Sheltered housing wardens, domiciliary care providers and alarm response centres have full access to the Wellbeing Monitor and can prioritise their care calls.  Kemuri is efficient to deploy.  The portable model is operational in ten seconds with no skill required.  The fixed model can be installed and tested within 15 minutes.  There are no rules to enter because the system learns patterns of activity.  Alerts are automatically sent to response centres or users of the app.  
Current and planned activity: 
Manufacturing batches of 100 units for trials/sales to housing associations/telecare service providers. First trials are in sheltered accommodation in County Durham in conjunction with Durham University (part of EU funded Erasmus+ project)

Controlled clinical trials required to collect evidence to support the benefits claimed (reducing impact of falls). Sample sizes to account for significant number of subjects continuing to live normally without any falls requiring intervention. Access to medical records/cost of treatment/health outcomes/discharge data/subsequent care pathways required

Kemuri collects accurate lifestyle data that can be used in clinical trials of drugs dispensed to people living independently including people with cognitive impairment/physical disability not able to record times of events/ambient conditions. KemuriSense power sockets can collect data for several years, in dementia trials it may be possible to identify rates of decline & use it to modify the care regime
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 

Note that the patent applies to more devices than a power socket.  It covers the internal electronics and components, which could be incorporated into any equipment consuming significant amounts of power. 

Kemuri and KemuriSense are registered trademarks.  
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
3
Regulatory Approvals:
The KemuriSense Smart Power Socket has been tested for EMC (Electro Magnetic Compliance) and CE certification. 

The product only measures ambient conditions and does not require certification as a medical device.
Commercial information:
We are building batches of 100 for field trials with availability in January 2017. 

The projected sales shown in the table below.



The growth accelerates as more telecare resellers become customers.

Current and potential telecare users: The Strategic Society Centre undertook a major quantitative research project entitled Who uses telecare? published in 2012 to explore usage of telecare among older people in England and identify potential users of telecare. It provided a conservative estimate based on 2008 data that among the over-50s in England, there were well over 1 million telecare users. However, by mapping individuals with similar conditions, the report was able to identify around 2.5 million more individuals living alone who may be able to benefit from telecare, and potentially as many as 4.1 million with conditions that could merit the use of telecare.

Further, the report stated that around 30% to 50 % of current telecare users paid for their telecare themselves or with the help of a family member. Among private and non-privately funded telecare users, it appears there is little difference in incomes. This suggests that relatively low income is not a barrier to individuals and their families funding telecare themselves or that most users can contribute to the cost of telecare support.
The report made recommendations to policymakers to aim to boost the usage of telecare to at least double current prevalence focusing on individuals living alone. It also recommended that policymakers and the industry should focus on targeting informal carers, including both cohabiting and non-cohabiting family carers as potential beneficiaries of greater usage of telecare.

Global telecare market: The global telecare market is valued at c. £1 billion per annum and is forecast by the Deloitte Centre for Health Solutions to grow at a rate of 5% per annum from now to 2018. The factors contributing to growth and market attractiveness are related to government initiatives and funding and the public willingness and receptivity towards technological advancement. The UK is the leading market for telecare products and services, with the UK telecare market share of up to 25% of the global market. Other prominent markets for telecare in terms of ageing populations that demand such services include France, Italy and Benelux (comprising Belgium, Luxemburg and the Netherlands).

Ireland, Malta, Singapore, Hong-Kong, Malaysia and Saudi Arabia as potential overseas markets for KemuriSense®, as those territories use British standard socket outlets.
Investment activity:
Kemuri was founded by Dr Leonard Anderson, Russell Anderson and Michael Anderson in January 2014.  Together, they worked on the concept for an older person’s carer assistance solution after failing to find a suitable product and service on the market.  The Company’s activity to date has been focused on product and web-services development and has been funded from private and public sources.  Kemuri’s proof-of-concept project was successfully completed in October 2015, assisted by grants from Innovate UK; £66,734 for a Smart Grant and £5,000 for a Smart Voucher. A £2,000 prize from Kent County Council paid for the first smart power socket prototype. 

Dr Anderson has provided an unsecured director's loan facility of £100,000.

Innovate UK sponsored £5000 research with the Institute of Ageing at Newcastle University for the Ethics of Passive Monitoring.

The company raised £545,000 in a private offer via West Hill Capital.  The funds are being deployed to refine the core product infrastructure, to develop the mobile app, to recruit staff across operations and to build an online sales platform. 

Kemuri has been awarded with €100,000 as a partner in an Erasmus + project for people-centred centred design.  Our UK partner is Durham University together with others in Netherlands, Czech Republic and Slovenia

The Company is a growth business and will not be cash generative in the short term as it invests heavily in developing the business in order to generate long-term profitable business relationships.

A key requirement is to find funding for an academic study to collect evidence for the value of predictive analytics for a period of at least one year.  Grants are being sought from multiple sources.
Regional Scalability:
Smart power socket production is scalable (batches of 100-1000 p.m) in the Woking production facility (larger volumes achieved by second sourcing manufacture). The Web technology is cloud-based & can be rapidly scaled by commissioning more servers/storage at short notice. WM scale-up can be generated by raising awareness with the following:
  • Social Services Commissioners/OTs
  • GP Surgeries, Mental Health & Hospital Trusts
  • Housing Associations & Voluntary Sector eg AgeUK
  • Telecare Service Companies
  • Local media/online sales websites 
Welbeing, our telecare service partner’s clients include WM local authorities & housing associations, providing installation & call monitoring services to any new customers in the region.

As a start-up our effort is directed to delivering reliable hardware & software with small sample numbers. Our design objective is for KemuriSense power sockets to operate continuously for at least 5 years. First trials have started in County Durham housing associations.
Measures:
In co-operation with an academic research partner, we hope to achieve the following in a trial:

Quality
  • Continuous reliable operation
  • Avoidance of false alerts
  • Recognising unattended falls, strokes or other episodes that result in a carer taking action that saved time and cost for medical intervention.
  • Peace of mind achieved for families and carers
  • Identifying trends that indicate the risk of hypothermia, dehydration and malnutrition.
  • Identifying activity at unusual times of day that lead to helpful family or medical intervention 
Safety
  • Electrical safety of products after installation in kitchens.
  • Security of personal data and avoidance of data loss. 
Cost
The trial budget is £500,000.  This would include the costs of selection, installation, monitoring, service support and surveying families throughout the trial.  Note that his includes detailed data analysis, medical services, the final report and communications.
 
People
The target group for research is a cohort that has these attributes:
  • Reject pendant alarms
  • Deny declining capacity
  • Want to live independently
  • Show symptoms of dementia
  • Need daily monitoring
A percentage will be used as a control group who are not included in the Trial.  The total numbers are to agreed by the academic research partner from one of the West Midlands universities.
 
Ethics
Finding volunteer older people and their next of kin will require access to the medical records and adult social care records of older people living alone.  This will also be needed during the trial to measure the times and costs of medical treatment.  Approval by the Ethics Committee will be required.  
Adoption target:
Assuming that there are 500,000 unused pendants in the UK, there are approximately 40,000 candidates for Kemuri wellbeing monitoring in a West Midlands population of 5 million.   

500 is a reasonable target for 2017/2018 – with an possibility of growing to 10,000 in 5 years.  
Investment sought:
A total investment of £500,000 over two years would provide a trial that provides evidence for wider adoption in the Region.  For budgeting purposes, this breaks down as follows:
  • £40,000 - Project Management
  • £100,000 – Installation and Web services for 120 older people and their families
  • £50,000 – Health service costs
  • £250,000 – Academic research costs
  • £60,000 – Kemuri cost to support the trial. 
The findings should be applicable throughout the UK. 

The objective is to obtain SBRI funding for the project.  
Read more
Hide details
Innovation 'Elevator Pitch':
ConCERT-D is an integrated clinical & research solution designed with Dementia leading clinical experts specifically for the treatment, identification & management of dementia patients, providing results and medication management. 
Overview of Innovation:
ConCERT-D displays captured mental assessment scores for tests including the Mini Mental State Examination (MMSE) in a graphical way enabling Clinicians to relate fluctuations in scores with events that would have happened in the meantime

The medication module allows Clinicians to keep track of the patient diagnosis, prescribed drugs, related side effects, allergies and other conditions. The in-built drug formulary is specially geared towards dementia patients. The accumulative anticholinergic cognitive burden (ACB) is automatically calculated allowing Clinicians to take better decisions, ultimately reducing the risks of cognitive impairment & death

The medication module enables Clinicians to check the dosages for antidepressants and anti-psychotics being taken by the patient as a percentage of the maximum dosage set for these medications

A Research Register for Clinicians to inform Clinical practice
The ability to easily identify patients and carers that match a clinical trial’s participation criteria provides a highly effective tool to increase participation in research. Researchers can build the appropriate participation criteria for clinical trials in ConCERT-D. The system can automatically report on patients that are eligible for participation in studies

Once a patient is identified the clinical researchers speaks to their carers for advice. In some cases internal background checks, tests and screening are carried out. If a patient is found to be suitable and willing to take part he/she is enrolled onto the clinical trial. On the other hand if found unsuitable the reason why is logged and the patient is automatically excluded from subsequent participant searches for that trial

ConCERT-D facilitates accreditation in programs including as The Memory Services National Accreditation Program (MSNAP) allowing hospitals to benchmark their services against national standards and provide quality assurances. MSNAP also enables staff to ensure they are making a meaningful difference to people’s lives as well as supporting implementation of national clinical excellence guidelines. ConCERT-D supports Clinicians to capture MSNAP information during interactions with the patient & then generate reports with the information gathered

These reports allow the identification of trends, assessment of completeness & are of great use for assessors when rewarding accreditation. This functionality can be adapted to other similar accreditation programs
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Standard  ConCERT-D Features
  • Easily displays results and key information for Clinicians on dashboards.
  • Allows Clinicians to keep track of the patient’s diagnosis, prescribed drugs, side effects, allergies, investigations, chronic conditions and lifestyle.
  • Enables Clinicians to relate fluctuations in assessment scores with events (medical, trial participation, etc.) that happen to the patient between assessments.
    This would be used to assist with identifying those about to go into Crisis
  • Reporting allows identification of trends within cohort and helps to manage consent better.
  • Automatically calculates the accumulative anticholinergic cognitive burden for drugs the patient is currently taking
  •  In-built drug formulary is specially geared towards dementia patients, where drugs includes the ACB scale 
  • Allows Clinicians to check the dosages of antidepressants and antipsychotics as a percentage of the dosage set for these medications
  • Allows the R&D department to list eligible participants and to manage consent for new or ongoing clinical trials that were never approached to take part in research. 
    • Linking people with dementia with high quality research has historically been very problematic. Registering an individual’s interest has proved very effective in earlier pilot work with DemReg but the new ConCERT-D system will allow us to embed the register fully in clinical practice as it acts as both a Research Register and an Electronic Patient Record. This will allow even more people to gain access to the high quality dementia research we undertake. 
      Dr Craig Ritchie - Honorary Consultant and R&D Director, WLMHT, Senior Lecturer, Imperial College London
  • Captures and manages consent by patients and carers
    Would  assist with the requirement for multi agency collaboration and gaining access to appropriate information to facilitate Crisis Care or data analytics
  • Facilitates accreditation in programmes such as MSNAP (Memory Services National Accreditation Programme)
Attached please find cost and financial benefits documents as a validation and evidence of time and cost savings.
 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Campaign Features
Whilst assisting the treatment and management of Dementia Patients the in a truly integrated clinical and research solution,  the software to provide reports to support the identification of trends that would assist with / facilitate a solution to the Meridian Challenges ‘Data Analytics to support better mental health and care’ and ‘Mental Health Crisis Care’ in providing a solution or stepping stone to provide ‘predictions of when a crisis is likely to occur’ as well as other aspects that are listed e.g.
  • Alerting Clinical & Mental Health professionals when risks of crisis are elevated
  • New ways for users to interact with care professionals through our presenting of valuable and up to date information - Service Transformation
  • Access for West Midlands service users, carers this level of access could be developed along with the other requirements outlined within the campaign. Many of these can be supplied via integration with our management tools and platforms.

6PM ConCERT-D solution would support the requirements within the ‘Data Analytics to support better mental health and care’ and ‘Mental Health Crisis Care’ campaigns.

With ConCERT-D and the other 6PM product suite including ‘Lilie’ (Sexual Health), Climate-HIV (HIV management tool), StrokePad, by utilising the mental health aspects and those aspects of these conditions that may have a bearing on their mental condition and subsequent reactions etc. These solutions would be enhanced with other products including CareSolutions™, a powerful data management and processing engine to enhance the Information Management environment related to Mental Health Crisis Care.
 
These solutions could either stand separately supporting these regional clinical areas or be bundled together to provide faster, appropriate care that safeguards patients and whilst answering may of the challenges mentioned with two or more of Meridians campaigns as indicated above.  
 
A secondary affect to adopting 6PM solutions would be to strengthen our position not only with UK but with the UK team, which is based within the West Midlands. We could see the 6PM UK team expanding with our products get a stronger foundation in the UK. 6PM would support the delivery and any potential development or customisation of solutions to accommodate regional and multi-agency requirements.
 
Current and planned activity: 
Currently
6PM is  currently supplying software solutions to 24 NHS trusts with a variety of healthcare products, including r the sexual health product ‘Lilie’ that is currently used by over 15,000 sexual health and HIV professionals throughout the UK
 
ConCERT-D has been operational at West London Mental Health Trust (WLMHT) since July 2014.Curent

Planned / required activity
  • Procurement / Adoption of our products: -  Require additional acute and community and specialist clinic sales and marketing products to CCGs and specialist clinical groups dealing with Dementia. Fully integrated with JDR to increase joint sales.
     
  • Evaluation / Validation / Clinical Trial – Would like to gain additional validation seeking a trial centre of this product (or any others).
     
  • Campaign Solution Developments Interested to hear and discuss how 6PM current solutions can be used or developed to meet ‘Meridian Campaigns’.
What is the intellectual property status of your innovation?:
ConCERT-D is jointly owned by 6PM Group & West London Mental Health Trust
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Regional Scalability:

Yes ConCERT-D can be scaled across a region.  It is a multi-tenant solution able to take a number of tenants (i.e. trusts) in one hosted solution where each tenant can have a number of sites.  Permissions allow for different options with regards to visibility of patient information between trusts.  The administration function of the system is managed centrally.   

Measures:

There is c.670,000 people living with dementia this is expected to double over 30 years. Only 40% of people with dementia receive a formal diagnosis, according to the Alzheimer’s Society two-thirds of people with dementia are cared for in the community.The ability exists to consolidate & enhance patient data already captured by clinical staff in existing primary/mental health software clinical applications. ConCERT-D is able to enrich dementia patient data & create a virtual electronic dementia patient record combining research tools. Additional clinical benefits is the ability to use real time patient data in clinical practice increasing quality of patient care. Issues include maintaining isolated dementia patient data within separate clinical software applications & not consolidated with research data, rather than in a seamless integrated solution to inform improvements in clinical practice by organisation, network & region or across England/UK.
 
ConCERT-D improves patient clinical outcomes by improving the data points on which the research is based. By collecting additional patient data from existing mental health solutions to integrate with clinical trials research, the research findings become more robust.
 
1 Additional patient data captured on specific medications management/prescribing allows patterns of reaction & clinical diagnosis to be monitored by fluctuations in assessments scores with events, this then allows for trending analysis
2 Research, by the selection & monitoring of patients for various clinical trials to be consented & monitored for adherence to accreditation programmes as MSNAP
3 To have collective “one stop” enriched combined dementia patient data (database) which can be extended across other organisations, networks, regions & UK
4 Analytical reports & patient search facilities for extending clinical trials & cohorts of patients including query database with ‘what-if’ options to understand clinical factors & trends leading to Dementia

Adoption target:

N/A

Read more
Hide details
3.5
4
Votes

Created by

Share and Follow